Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function.
primary studies published RCT
Details- 2003
- Wood LG
Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin.
primary studies published RCT
Details- 2002
- Alothman GA
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis.
primary studies published RCT
Details- 2002
- App EM
Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis.
primary studies published RCT
Details- 2002
- Ballmann M
The long-term use of inhaled tobramycin in patients with cystic fibrosis.
primary studies published RCT
Details- 2002
- Bowman CM
A randomized, controlled trial of a community-based support program for families of children with chronic illness: pediatric outcomes.
primary studies published RCT
Details- 2002
- Chernoff RG
Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.
primary studies published RCT
Details- 2002
- Equi A
Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis.
primary studies published RCT
Details- 2002
- Eubanks V
Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.
primary studies published RCT
Details- 2002
- Francisco MP
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.
primary studies published RCT
Details- 2002
- Hodson ME